New Blood Test Detects Multiple Cancers and Diseases
New low-cost blood test detects multiple cancers & diseases using DNA methylation patterns. Identifies disease origin with high specificity.
New low-cost blood test detects multiple cancers & diseases using DNA methylation patterns. Identifies disease origin with high specificity.
The FDA has cleared a new at-home HPV test kit, expanding access to cervical cancer screening and potentially reducing related mortality.
New blood test uses gut microbiome markers for early dementia detection, achieving over 80% accuracy in identifying mild cognitive impairment.
A new AI model shows over 96% accuracy in early lung cancer detection from CT scans, potentially improving survival rates.
Changes in the gut microbiome may serve as an early indicator for Parkinson's disease, potentially enabling earlier detection and intervention strategies.
New blood test for pTau217 detects Alzheimer's indicators years before symptoms, aiding early risk identification and clinical trial design.
Turkey's Ministry of Health reported 750,000 glaucoma diagnoses in 2025, stressing early detection's vital role in preventing irreversible vision loss.
Kidney stone pain acts as a vital early warning system, prompting patients to seek medical help for kidney health, according to Prof. Dr. Fikret Halis.
Glaucoma is the leading cause of irreversible blindness, with early detection through regular eye exams being crucial due to its often symptomless progression.